Docetaxel

Država: Novi Zeland

Jezik: engleski

Izvor: Medsafe (Medicines Safety Authority)

Aktivni sastojci:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Dostupno od:

REX Medical Ltd

INN (International ime):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

Doziranje:

20 mg/mL

Farmaceutski oblik:

Concentrate for infusion

Sastav:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Jedinice u paketu:

Vial, glass, Diluent, 1.5 mL

Razred:

Prescription

Tip recepta:

Prescription

Proizveden od:

Cipla Ltd

Terapijske indikacije:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Proizvod sažetak:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Datum autorizacije:

2006-06-23